FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Creatine Kinase-MB

K Number: K162526 · Decision May 26, 2017
Classifications
1
FEI Numbers
6
Registration Numbers
6
Same Product Code
26
Applicant Total
183
Review Days
259

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Creatine Kinase-MB
K Number
K162526
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1215
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics
Date Received
September 9, 2016
Decision Date
May 26, 2017
Product Code
JHW
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
JHW U.V. Method, Cpk Isoenzymes

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (JHW), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics

K Number Device Name
K252323 cobas pulse blood glucose monitoring system
K252280 Elecsys Anti-SARS-CoV-2 S
K260048 Elecsys Anti-HAV IgM
K260049 Elecsys Anti-HBc IgM
K260046 Elecsys Anti-HBc II
K260026 Tina-quant Cardiac high sensitivity CRP III
K253490 Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions
K253491 ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions
K253839 Elecsys Anti-SARS-CoV-2
K253188 CoaguChek XS Plus System
Search all 183 clearances from Roche Diagnostics →